185 related articles for article (PubMed ID: 28574280)
1. Current Concepts in Diagnosis, Molecular Features, and Management of Lobular Carcinoma In Situ of the Breast With a Discussion of Morphologic Variants.
Ginter PS; D'Alfonso TM
Arch Pathol Lab Med; 2017 Dec; 141(12):1668-1678. PubMed ID: 28574280
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas.
Calle C; Kuba MG; Brogi E
Breast J; 2020 Jun; 26(6):1148-1155. PubMed ID: 32500575
[TBL] [Abstract][Full Text] [Related]
3. The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS.
Brogi E
Virchows Arch; 2022 Dec; 481(6):823-837. PubMed ID: 35567633
[TBL] [Abstract][Full Text] [Related]
4. Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations.
Harrison BT; Nakhlis F; Dillon DA; Soong TR; Garcia EP; Schnitt SJ; King TA
Mod Pathol; 2020 Jul; 33(7):1287-1297. PubMed ID: 31932682
[TBL] [Abstract][Full Text] [Related]
5. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.
De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA
Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Coexisting Lobular Carcinoma In Situ With Invasive Lobular Carcinoma.
Harbhajanka A; Lamzabi I; Syed S; Jain R; Ghai R; Reddy VB; Bitterman P; Gattuso P
Appl Immunohistochem Mol Morphol; 2016; 24(10):738-743. PubMed ID: 26574630
[TBL] [Abstract][Full Text] [Related]
8. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
Foschini MP; Miglio R; Fiore R; Baldovini C; Castellano I; Callagy G; Bianchi S; Kaya H; Amendoeira I; Querzoli P; Poli F; Scatena C; Cordoba A; Pietribiasi F; Kovács A; Faistova H; Cserni G; Quinn C
Eur J Surg Oncol; 2019 Dec; 45(12):2279-2286. PubMed ID: 31301938
[TBL] [Abstract][Full Text] [Related]
10. Apocrine Variant of Pleomorphic Lobular Carcinoma In Situ: Further Clinical, Histopathologic, Immunohistochemical, and Molecular Characterization of an Emerging Entity.
Zhong E; Solomon JP; Cheng E; Baum J; Song W; Hoda SA
Am J Surg Pathol; 2020 Aug; 44(8):1092-1103. PubMed ID: 32317606
[TBL] [Abstract][Full Text] [Related]
11. Lobular Carcinoma In Situ.
Wen HY; Brogi E
Surg Pathol Clin; 2018 Mar; 11(1):123-145. PubMed ID: 29413653
[TBL] [Abstract][Full Text] [Related]
12. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.
Rieger-Christ KM; Pezza JA; Dugan JM; Braasch JW; Hughes KS; Summerhayes IC
Mol Pathol; 2001 Apr; 54(2):91-7. PubMed ID: 11322170
[TBL] [Abstract][Full Text] [Related]
13. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center.
Shamir ER; Chen YY; Chu T; Pekmezci M; Rabban JT; Krings G
Am J Surg Pathol; 2019 Mar; 43(3):399-408. PubMed ID: 30489319
[TBL] [Abstract][Full Text] [Related]
15. Lobular carcinoma in situ: diagnostic criteria and molecular correlates.
Sokolova A; Lakhani SR
Mod Pathol; 2021 Jan; 34(Suppl 1):8-14. PubMed ID: 33024303
[TBL] [Abstract][Full Text] [Related]
16. The Pathologic Finding of Combined Lobular Carcinoma
Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
Shah V; Nowinski S; Levi D; Shinomiya I; Kebaier Ep Chaabouni N; Gillett C; Grigoriadis A; Graham TA; Roylance R; Simpson MA; Pinder SE; Sawyer EJ
Breast Cancer Res; 2017 Jan; 19(1):7. PubMed ID: 28095868
[TBL] [Abstract][Full Text] [Related]
18. Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status.
Mao K; Yang Y; Wu W; Liang S; Deng H; Liu J
PLoS One; 2017; 12(5):e0176417. PubMed ID: 28467490
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.
Shamir ER; Chen YY; Krings G
Mod Pathol; 2020 Jun; 33(6):1078-1091. PubMed ID: 31907376
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ.
Masannat YA; Husain E; Roylance R; Heys SD; Carder PJ; Ali H; Maurice Y; Pinder SE; Sawyer E; Shaaban AM
Breast; 2018 Apr; 38():120-124. PubMed ID: 29310036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
